USPTO trademark

NEOMAB

RegisteredUSPTOWord markClass 42

"NEOMAB" is a word mark owned by GemPharmatech Co., Ltd., filed at the USPTO on February 22, 2024. It is registered and covers class 42 (Computer and Scientific Services).

View GemPharmatech Co., Ltd. portfolioGet this data via the API
Official USPTO record
NEOMAB trademark as filed
As filed with the USPTO
Status
Registered
Since December 10, 2024
Filed
February 22, 2024
Registered
December 10, 2024
Expires
Not recorded
Application no.
98417072
Registration no.
7599395
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns NEOMAB

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GemPharmatech Co., Ltd.

Nanjing, Jiangsu, China

31 trademarks in the portfolioView company

Representative

Nazly Aileen Bayramoglu

Bayramoglu Law Offices LLC

Goods and services

What the mark covers

The products and services NEOMAB is filed for, grouped by Nice class.

  • Biological research; Chemical research; Conducting of feasibility studies in the field of new technologies; Culturing of cells for others for scientific research purposes; Medical research; Research and development of new products for others; Research in the field of gene editing technology; Scientific laboratory services; Scientific research; Scientific research in the field of genetics

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Assigned to examiner
  8. New application office supplied data entered
  9. New application entered
FAQ

About NEOMAB

Who owns the trademark "NEOMAB"?

The USPTO trademark "NEOMAB" (application 98417072) is owned by GemPharmatech Co., Ltd.

What is the status of "NEOMAB"?

Its status at the USPTO is: registered.

When was "NEOMAB" registered?

It was registered on December 10, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NEOMAB and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2ca0-6fb1-76bc-a7f9-104d1ca323ff
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ca0-6fb1-76bc-a7f9-104d1ca323ff",
  "object": "trademark",
  "mark_text": "NEOMAB",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98417072",
  "filing_date": "2024-02-22",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "GemPharmatech Co., Ltd.",
      "entity_id": "ent_019eb7dd-5b13-70cd-880d-9b7bc5be78fb"
    }
  ]
}